Tumgik
#Global Acute Ischemic Stroke Diagnosis And Treatment Market World Acute Ischemic Stroke Diagnosis And Treatment Market Europe Acute Ischemic
bearni · 3 years
Text
Global Acute Ischemic Stroke Diagnosis and Treatment Market By Type (Computed Tomography (CT),Magnetic resonance imaging (MRI),Carotid Ultrasound,Cerebral Angiography,Electrocardiography,Echocardiography), By Application (Tissue Plasminogen ActivatorAnticoagulantAntiplateletAntihypertensive), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Industry analysis and future outlook on Acute Ischemic Stroke Diagnosis and Treatment Global Market brings a systematic perspective of the market execution and assists in strategic decision making for worldwide and additionally the regional situation. Detailed sections provides in-depth arrangement, the Acute Ischemic Stroke Diagnosis and Treatment contemplate that make sense of different perspectives relating to the global market. To begin with, the Acute Ischemic Stroke Diagnosis and Treatment market definition, applications, arrangement, and industry esteem chain structure are incorporated into the answer, to target gathering of people on restricting Acute Ischemic Stroke Diagnosis and Treatment market elements including drivers, limitations, openings, patterns, applications, topographical/local Acute Ischemic Stroke Diagnosis and Treatment markets, and aggressive scene.
Global Acute Ischemic Stroke Diagnosis and Treatment Industry Market was valued at USD XX Million in the year 2020. The market is further estimated to grow at a CAGR of XX% from 2020 to reach USD XX Million by the year 2029.
Get Quick Free Sample Brochure report at: https://www.globalresearchview.com/report/global-acute-ischemic-stroke-diagnosis-a/GRV52867/request-sample/
Acute Ischemic Stroke Diagnosis and Treatment market rivalry by top makers/players, with Acute Ischemic Stroke Diagnosis and Treatment deals volume, Value (USD/Unit), Revenue (Mn/Bn USD) and market size for every producer/player; the significant players include:
Abbott Medtronic Boston Scientific Cordis Philips GE Healthcare Siemens Stryker Genentech Merck
Worldwide Acute Ischemic Stroke Diagnosis and Treatment statistical surveying report uncovers that the Acute Ischemic Stroke Diagnosis and Treatment business will develop with pivotal CAGR over the estimated forecast period of 2021 and 2029. The global Acute Ischemic Stroke Diagnosis and Treatment market in forecast years 2021-2029, is expected to hit Mn/Bn$ XX USD by 2029. The Acute Ischemic Stroke Diagnosis and Treatment market gives broad development openings over the both created and creating economies. Further, the Acute Ischemic Stroke Diagnosis and Treatment business sectors could profit without a doubt from the expanding interest to bring down Acute Ischemic Stroke Diagnosis and Treatment expenses of treatment over the globe.
Inquiry for Buying report to get customization at: https://www.globalresearchview.com/report/global-acute-ischemic-stroke-diagnosis-a/GRV52867/inquiry
Key Highlights of the Report:
Acute Ischemic Stroke Diagnosis and Treatment Market Report provides forecast and industry outlook for the period of 2021-2029 with 2020 as the base year and covering historic data for years 2015-2019.
Acute Ischemic Stroke Diagnosis and Treatment Market outlook with Porter’s 5 Forces Analysis will provide market dynamics (Drivers, Restraints, Opportunities & Threats).
Acute Ischemic Stroke Diagnosis and Treatment Competitive landscape section gives you the competitive edge over other key players in the market (Key Business Strategies, Recent Development M&A, Company Overview, Products/Services Portfolio & Financial Overview).
Acute Ischemic Stroke Diagnosis and Treatment Technological Scenarios & Expected Developments.
Acute Ischemic Stroke Diagnosis and Treatment End-Use Industry & Consumer Behaviour Trends.
Acute Ischemic Stroke Diagnosis and Treatment Export-Import Scenario.
Acute Ischemic Stroke Diagnosis and Treatment Regulatory Policies across each region.
Acute Ischemic Stroke Diagnosis and Treatment In-depth analysis on Industry Trends & Dynamics across each segment covered in the report.
Based on Type, Acute Ischemic Stroke Diagnosis and Treatment market report shows development rate of each type, covers:
Computed Tomography (CT) Magnetic resonance imaging (MRI) Carotid Ultrasound Cerebral Angiography Electrocardiography Echocardiography
End clients/applications, Acute Ischemic Stroke Diagnosis and Treatment market report centers around the status and viewpoint for best applications/end clients, development rate for every application, this can be isolated into:
Tissue Plasminogen Activator Anticoagulant Antiplatelet Antihypertensive
Access More Information at: https://www.globalresearchview.com/report/global-acute-ischemic-stroke-diagnosis-a/GRV52867
In conclusion, the global Acute Ischemic Stroke Diagnosis and Treatment industry report unveils research finding, outcomes, conclusions. Likewise, disclose various Acute Ischemic Stroke Diagnosis and Treatment data sources, traders/vendors, suppliers, manufacturers, sales channel, and addendum. In short, the overall Acute Ischemic Stroke Diagnosis and Treatment report is a lucrative document for people implicated in Acute Ischemic Stroke Diagnosis and Treatment market.
Global Impact of COVID-19 Analysis:
COVID19 is an unrivaled global public health emergency that affects almost every industry, so the projected long-term impact will affect industry growth over the forecast period. The report provides insights into COVID19, taking into account changes in consumer behavior and demand, purchasing behavior, supply chain diversion, the dynamics of current market forces, and significant government intervention. Insights, analysis, estimates and forecasts considering the impact of COVID19 on the market.
About Us:
GlobalResearchView (GRV) is one of the leading market research company which aims to serve the most excellent research to the various sectors of business. We are prominent in satisfying all kinds of market research needs.
Contact US:
Jennifer Da (Head Global Business Development) – Global Research View(GRV) 701, Milton Avenue, East Ham,London. United kingdom. Pincode - 4E6 1BN Email: [email protected] Websites:  www.globalresearchview.com Tel: +44 020 8638 7098
0 notes
shytriumphbanana · 3 years
Text
Acute Ischemic Stroke Diagnosis and Treatment Market to Witness the Highest Growth Globally in the Next 2022-2030
Global Acute Ischemic Stroke Diagnosis and Treatment Market to 2030 is a fundamental study by Market.biz. The research report helps capture the attention of leaders like you by providing insights into Acute Ischemic Stroke Diagnosis and Treatment market share and growth. This report has analyzed data representing capital gains and losses both globally and locally. Competent standardized tools used during report writing include a SWOT analysis. The report provides a comprehensive judgment of the market. The report comprises the market revenue, production earnings, distribution players, development factors, and applications.
The report also creates a clear picture of the various factors that will drive the global Acute Ischemic Stroke Diagnosis and Treatment market in the coming years. To help companies spot potential threats and give them a clear picture of the opportunities that exist in the Acute Ischemic Stroke Diagnosis and Treatment industry, the report offers a SWOT analysis of the global market. For the purposes of the study, market analysts have used rigorous primary and secondary research techniques. This makes analysis and forecasts more accurate and helps analysts examine the market from a broader perspective. In addition, the market size of Acute Ischemic Stroke Diagnosis and Treatment has been discussed in-depth, in terms of revenue and sales volume, in addition to the list of top players.
Market estimates:
• Projected Value (2021): $ 1,044.8 Mn
• Forecast Value (2030): $ 1,459.8 Mn
• CAGR Rate (%): 3.4%
Request a sample report below:
https://market.biz/report/global-acute-ischemic-stroke-diagnosis-and-treatment-market-gm/#requestforsample
**Note: You must use a corporate email address or business details.
Which Suggestions Are Covered In The Acute Ischemic Stroke Diagnosis and Treatment Market Research Study?
The Acute Ischemic Stroke Diagnosis and Treatment Market Report | Clarified regarding the regional landscape of the industry:
1. According to the report, the geographic scope of the Acute Ischemic Stroke Diagnosis and Treatment market has been meticulously segmented into North America, South & Central America, Europe, Asia-Pacific, Middle East, and Africa.
2. The research lists the consumption market share of each region in minute detail, along with the production market share and revenue.
3. In addition, the report includes the expected growth rate for each region over the estimated period.
4. Leading Manufacturers, Exporters and Retailers (if any) from around the world are analyzed for this research report with respect to their company profile, product portfolio, capacity, price, cost and revenue. For the competitor segment, the report covers the following key players of the global Acute Ischemic Stroke Diagnosis and Treatment market and some other small players:
Abbott, Medtronic, Boston Scientific, Cordis, Philips, GE Healthcare, Siemens, Stryker, Genentech, Merck
5. For the type segment, this report focuses on the status and outlook of the product type. The types of Acute Ischemic Stroke Diagnosis and Treatment key are:
Computed Tomography (CT) Magnetic resonance imaging (MRI) Carotid Ultrasound Cerebral Angiography Electrocardiography Echocardiography
6. For the Applications/End Use segment, this report focuses on the status and outlook for key applications. The main applications of Acute Ischemic Stroke Diagnosis and Treatment are:
Tissue Plasminogen Activator Anticoagulant Antiplatelet Antihypertensive
Don't see what you're looking for? Ask here below:
https://market.biz/report/global-acute-ischemic-stroke-diagnosis-and-treatment-market-gm/#inquiry
7. For the geographic segment, regional supply, application, and major players in the Acute Ischemic Stroke Diagnosis and Treatment market, demand, price are presented from 2021 to 2030, covering:
North America (Panama, Mexico, Barbados, United States, Canada, Puerto Rico, Trinidad and Tobago, etc.).
South and Central America (Brazil, Chile, Argentina, Belize, Costa Rica, Panama, Guatemala, El Salvador).
Europe (Spain, Belgium, France, Holland, Germany, Sweden, Switzerland, San Marino, Ireland, Norway, Luxembourg, etc).
Asia-Pacific (Qatar, China, India, Hong Kong, Korea, Israel, Australia, Singapore, Japan, Kuwait, Brunei, etc.).
Middle East and Africa (United Arab Emirates, Egypt, Algeria, Nigeria, South Africa, Angola, Saudi Arabia, Bahrain, Oman, Turkey, Lebanon, etc.).
Why should I buy Acute Ischemic Stroke Diagnosis and Treatment Market Report?
Develop a business strategy by identifying high-growth, attractive Acute Ischemic Stroke Diagnosis and Treatment market categories.
Develop a competitive strategy based on a competitive landscape.
Design capital investment strategies based on forecasted high-potential Acute Ischemic Stroke Diagnosis and Treatment segments.
Identify potential Acute Ischemic Stroke Diagnosis and Treatment business partners, acquisition targets, and business buyers.
Plan the launch and inventory of a new product in advance.
Prepare strategic and management presentations using market data from Acute Ischemic Stroke Diagnosis and Treatment.
Recent events and developments.
In more detail, the chapters of this report contain the following topics:
Chapter 1: Consists of the research objective and assumption Acute Ischemic Stroke Diagnosis and Treatment.
Chapter 2: Introduces the Acute Ischemic Stroke Diagnosis and Treatment Market; analyzes the different market segmentations; summarize the report.
Chapter 3: Includes Acute Ischemic Stroke Diagnosis and Treatment market drivers, restraints, opportunities, and trends that contribute to market growth. The dynamic section of the report also includes Direct Impact Analysis, Orbit of Opportunity, PEST Analysis, and Porter's Five Analysis.
Chapter 4: Examines the global Acute Ischemic Stroke Diagnosis and Treatment market, providing sales figures and market shares. The chapter also discusses market forecasts, factors enabling growth, and the future of the market, which covers the period 2020-2030. In addition, it provides detailed in-depth analysis and forecasts of the submarkets.
Chapter 5:  Provides an in-depth and comprehensive analysis of the regional and country Acute Ischemic Stroke Diagnosis and Treatment markets. The chapter goes on to provide market forecasts, details on growing regions, factors enabling growth, drivers and restraints at the country level, developments during 2021 and their influence during the forecast period, and future market predictions, covering the period 2021 -2030.
Chapter 6: Identifies and analyzes the major market players and innovative and growing companies that will impact the future of the Acute Ischemic Stroke Diagnosis and Treatment industry.
Chapter 7: Explains the company's research methodology for creating rich insights for customers from millions of data points.
Buy direct Our report (2021 Edition) below:
https://market.biz/report/global-acute-ischemic-stroke-diagnosis-and-treatment-market-gm/
Thanks for reading this article, you can also get a custom section separated by chapters or report editions Acute Ischemic Stroke Diagnosis and Treatment by regions.
Contact Us:
Market.Biz (Developed by Prudour Pvt. Ltd.)
Phone: +1(857)4450045
Our blogs:
https://marketsucessindustry.wordpress.com/
0 notes
ihealthcareanalyst · 8 years
Text
Global Acute Ischemic Stroke Diagnosis and Treatment Market USD 1.7 Billion by 2020
Acute ischemic stroke is characterized by the sudden loss of blood circulation to an area of the brain, resulting in a corresponding loss of neurologic function. Acute ischemic stroke is caused by thrombotic or embolic occlusion of a cerebral artery and is more common than hemorrhagic stroke. Different imaging studies, including computed tomography, magnetic resonance imaging, computed tomographic angiography, magnetic resonance angiography, and perfusion studies, are useful for evaluation of acute stroke.
Acute Ischemic Stroke Diagnosis and Treatment Market 2016-2020 report estimates the global acute ischemic stroke diagnosis and treatment market to reach nearly USD 1.7 Billion in 2020, at a CAGR of 5.5% from 2016 to 2020 – iHealthcareAnalyst, Inc.
Visit the Acute Ischemic Stroke Diagnosis and Treatment Market 2016-2020 report https://www.ihealthcareanalyst.com/report/acute-ischemic-stroke-diagnosis-and-treatment-market/
The global acute ischemic stroke diagnosis and treatment market report provides market size (Revenue USD Million 2013 to 2020), market share, market trends and forecasts growth trends (CAGR%, 2016 to 2020).
The global acute ischemic stroke diagnosis and treatment market segmentation is based on diagnostics type (computed tomography, magnetic resonance imaging, ultrasound, cerebral angiography, nuclear imaging), and surgery types (carotid endarterectomy, angioplasty, endovascular mechanical thrombectomy). The global acute ischemic stroke diagnosis and treatment market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Diagnostics Type 1.1 Computed Tomography 1.2 Magnetic Resonance Imaging 1.3 Ultrasound 1.4 Cerebral Angiography 1.5 Nuclear Imaging 1.6 Others
2. Surgery Type 2.1 Carotid Endarterectomy 2.2 Angioplasty 2.3 Endovascular Mechanical Thrombectomy
3. Geography (Region, Country) 3.1 North America (U.S., Canada) 3.2 Latin America (Brazil, Mexico, Rest of LA) 3.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU) 3.4 Asia Pacific (Japan, China, India, Rest of APAC) 3.5 Rest of the World
4. Company Profiles 4.1 Abbott Laboratories 4.2 Covidien PLC 4.3 Johnson & Johnson 4.4 Penumbra, Inc. 4.5 Philips Healthcare 4.6 GE Healthcare 4.7 Hitachi, Ltd. 4.8 Siemens Healthcare 4.9 Stryker Corporation
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: [email protected] Website: http://www.ihealthcareanalyst.com
- https://www.ihealthcareanalyst.com/global-acute-ischemic-stroke-diagnosis-treatment-market/
0 notes
niteshagrawals-blog · 6 years
Text
Ischemic strokes Market Worldwide Key Players Forecasts by Revenue, Growth Rate Till 2023
Market Scenario: 
Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. According to the World Health Organization (WHO), stroke accounts for around 17 million deaths annually. As per the Centers for Disease Control and Prevention (CDC), stroke leads to 1 out of every 20 deaths costing around USD 34 billion each year in the U.S. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.
The key strategies adopted by leading industry players incldues new product launches and collaborations. For instance, in April 2016, the novel TransCarotid Artery Revascularization (TCAR) procedure launched by Silk Road Medical, Inc, received FDA approval. This minimally invasive technique is designed to access the common carotid artery. Moreover, in March, 2015, WATCHMAN, a closure device designed to prevent stroke in patients with atrial fibrillation received FDA approval.
Rising cases of ischemia stroke are driving the demand for surgical procedures in stroke treatment. Increasing demand for minimally invasive procedures and advancements in surgical procedures are the key factors boosting the growth of the global ischemic stroke market. High cost of the surgical procedures and excessive usage of medication for the treatment of ischemic stroke are hindering the market growth.
The global market for ischemic stroke is expected to grow at a CAGR of approximately 8.3% during the forecast period 2017-2023.
Get Exclusive PDF Sample Report @ https://www.marketresearchfuture.com/sample_request/5423
Key Players for Ischemic Stroke Market:
The emergence of new and cost-effective medication options for the treatment of ischemic stroke could open up new opportunities to the new players in the global ischemic stroke market. Additionally, emerging markets, such as India and China, could also open new opportunities to new players.
·         Abbott Laboratories (U.S.)
·         Medtronic plc (U.S.)
·         Boston Scientific Corporation (U.S.)
·         Cordis Corporation (U.S.)
·         Koninklijke Philips N.V. (Netherland)
·         GE Healthcare (U.S.)
·         Stryker Corporation (U.S.)
·         Genentech, Inc. (U.S.)
·         Merck & Co., Inc. (U.S.)
·         Bayer AG (Germany)
·         Boehringer Ingelheim (Germany)
·         Sanofi (France)
·         Covidien plc (Ireland)
·         Philips Healthcare (U.S.)
·         Johnson & Johnson (U.S.)
·         Penumbra, Inc. (U.S.)
·         GE Healthcare (U.S.)
·         Siemens Healthcare (U.S.)
·         Hitachi, Ltd (Japan)
·         Biogen (U.S.)
·         Daiichi Sankyo (U.S.)
·         Pfizer Inc. (U.S.), and others
Intended Audience:
Ischemic Stroke Drug Suppliers
Ischemic Stroke Drug     Manufacturers
Research and Development     (R&D) Companies
Medical Research Laboratories
Academic Medical Institutes and     Universities
Global Ischemic Stroke Market: Segmentation 
The ischemic stroke is segmented on the basis of diagnosis, drug class, surgery and end-users.
On the basis of the diagnosis, the market is segmented into Computed Tomography (CT), Magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others.
On the basis of the drug class, the market is segmented into tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive, and others
On the basis of the surgery, the market is segmented into carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy
On the basis of the end-user, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.
Global Ischemic Stroke Market: Regional Analysis
The global ischemic stroke market consists of countries namely America, Europe, Asia Pacific, and the Middle East and Africa.
The Americas has emerged as the largest market for the global ischemic stroke owing to the favorable government initiatives, technological innovations, and increasing demand for ischemic stroke products. According to the American Heart Association, ischemic stroke is among the top three causes of death in the U.S. and Canada, nearly 795,000 patients suffering from strokes are treated in the 2014.
Europe is the second largest global ischemic stroke market owing to the advancements in the surgical devices technology along with the rising occurrence of acute ischemia stroke cases among the patients. In the European Union, over 31 million people are living with diabetes aged between 20 and 79. This signifies an average diabetes prevalence rate of 8.6% of the adult population. Some other factors driving the market includes the growing percentage of diabetes mellitus population mainly in the developed countries of Europe
Asia Pacific is anticipated to unfold as the most promising market for the global ischemic stroke owing to increasing prevalence of stroke cases in this region. China and India are considered as a big market for ischemic stroke within the forecast period. Manufacturers are expanding their operations in Asia Pacific region as these regions hold immense potential for the market growth.
The Middle East region is expected to grow at a faster rate due to the factors such as the extensive development of healthcare infrastructure and growing emphasis on research and development in the healthcare sector.
Some Brief Table of Contents of Report
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
TOC Continued…
Need more Information Ask to Our Experts @ https://www.marketresearchfuture.com/enquiry/5423
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
0 notes
Text
Acute Ischemic Stroke Diagnosis and Treatment Market Size, Share, Segment Analysis, Growth Drivers and Forecast to 2023
Tumblr media
Acute ischemic stroke refers to a sudden loss of certain brain function owing to uneven or lack of blood to the brain. Acute ischemic functions are mainly triggered by atherosclerosis plaques blocking blood vessels, blood clots locking the blood distribution to or from arteries nourishing the brain, or narrowing of blood vessels of the brain. Acute ischemic stroke is one of the major causes of permanent disability in the patients. It is also the third largest reason of death worldwide. Acute ischemic stroke can affect persons of all age groups. However, acute ischemic stroke most commonly affects the individuals, who are above 60 years, the risk of acute ischemic stroke increases with age. Driven by the technical advancement in diagnosis, the acute ischemic stroke diagnosis and treatment demand is expected to experience an escalating demand in coming years.
Explore Request Sample at: https://www.psmarketresearch.com/market-analysis/acute-ischemic-stroke-diagnosis-and-treatment-market/report-sample
Based on the various diagnosis and treatment the global acute ischemic stroke diagnosis and treatment market can be segmented as computed tomography, magnetic resonance imaging, ultrasound, cerebral angiography, nuclear imaging, and others. Based on the various surgery types the global acute ischemic stroke diagnosis and treatment market can be broadly segmented as carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy.
Browse Report at: https://www.psmarketresearch.com/market-analysis/acute-ischemic-stroke-diagnosis-and-treatment-market
North America was the largest market of acute ischemic stroke diagnosis and treatment in 2014. The market dominance of the North America is attributed to high percentage of patients suffering from strokes, in admiration with the technical advancement in the treatment procedure acute ischemic stroke in the region. It is then followed by Europe; the large population of baby boomers in Europe is one of the factors for a high market share in acute ischemic stroke diagnosis and treatment market. Country wise, the U.S., Canada are two of the major markets in North America. Germany, Italy, the U.K, and France are some of the dominant market in Europe, Japan, China and India are the major market of Asia Pacific region.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact: P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Web: https://www.psmarketresearch.com
Connect with us: LinkedIn | Twitter | Google + | Facebook
0 notes
Acute Ischemic Stroke Diagnosis and Treatment Market Value Projected to Expand by 2020
Transparency Market Research announces the release of a new research report titled “Acute Ischemic Stroke Diagnosis and Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”. According to the report, driven by technological advancement, growing prevalence of strokes, and high success rate of treatment surgeries, the global acute ischemic stroke diagnosis and treatment market is likely to expand at a 6.30% CAGR from 2014 to 2020, growing from US$1.2 bn to US$1.9 bn during that time.
Based on type of diagnosis, the acute ischemic stroke diagnosis and treatment market is divided into CT, nuclear imaging, cerebral angiography, MRI, ultrasound, and others. While high efficiency and effectiveness of CTs enabled them to dominate the overall market, this segment is anticipated to witness limited demand by 2020 owing to technological complexities and high cost of diagnosis.
 Request to View Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1799
 On the basis of type of surgery, the acute ischemic stroke diagnosis and treatment market is segmented into carotid endarterectomy, endovascular mechanical thrombectomy, and angioplasty. While carotid endarterectomy dominated the overall market thanks to short treatment duration, high success rate, and easy availability, this segment is anticipated to lose market share over the next five years owing to high risk of side effects.
Geographically, the global acute ischemic stroke diagnosis and treatment market is divided into Asia Pacific, Europe, North America, and Rest of the World. Primarily driven by the rise in acute ischemic stroke surgeries and availability of technologically advanced medical equipment and devices, North America dominates the worldwide acute ischemic stroke diagnosis and treatment market. The American Heart Association states that every year, an estimated 795,000 patients are diagnosed with stroke in the US, a whopping 85.0% of which are identified as acute ischemic stroke. Seeing that the cost of treating strokes in the country surpasses US$73 bn per year, the North America acute ischemic stroke diagnosis and treatment market is anticipated to retain its lead through 2020.
 Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1799
 Europe is the second largest market and is mainly fueled by a large population base of geriatrics. Identified as the most rapidly developing regional market for acute ischemic stroke diagnosis and treatment, Asia Pacific is driven by growing awareness among people, increasing number of global companies turning their focus to developing countries in APAC, expanding pool of potential patients, and rising investments in the region.
Some of the leading companies making a significant contribution towards the growth of the global acute ischemic stroke diagnosis and treatment market are Stryker Corporation, Abbott Laboratories, Hitachi, Ltd., Covidien plc, Siemens Healthcare, Penumbra, Inc., GE Healthcare, Philips Healthcare, and Johnson & Johnson.
 Enquiry for discount on this report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1799
 About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
 US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: http://www.transparencymarketresearch.com
Acute Ischemic Stroke Diagnosis and Treatment Market Growth, Trends and Forecast up to 2020
Transparency Market Research announces the release of a new research report titled “Acute Ischemic Stroke Diagnosis and Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”. According to the report, driven by technological advancement, growing prevalence of strokes, and high success rate of treatment surgeries, the global acute ischemic stroke diagnosis and treatment market is likely to expand at a 6.30% CAGR from 2014 to 2020, growing from US$1.2 bn to US$1.9 bn during that time.
Based on type of diagnosis, the acute ischemic stroke diagnosis and treatment market is divided into CT, nuclear imaging, cerebral angiography, MRI, ultrasound, and others. While high efficiency and effectiveness of CTs enabled them to dominate the overall market, this segment is anticipated to witness limited demand by 2020 owing to technological complexities and high cost of diagnosis.
 Request to View Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1799
 On the basis of type of surgery, the acute ischemic stroke diagnosis and treatment market is segmented into carotid endarterectomy, endovascular mechanical thrombectomy, and angioplasty. While carotid endarterectomy dominated the overall market thanks to short treatment duration, high success rate, and easy availability, this segment is anticipated to lose market share over the next five years owing to high risk of side effects.
Geographically, the global acute ischemic stroke diagnosis and treatment market is divided into Asia Pacific, Europe, North America, and Rest of the World. Primarily driven by the rise in acute ischemic stroke surgeries and availability of technologically advanced medical equipment and devices, North America dominates the worldwide acute ischemic stroke diagnosis and treatment market. The American Heart Association states that every year, an estimated 795,000 patients are diagnosed with stroke in the US, a whopping 85.0% of which are identified as acute ischemic stroke. Seeing that the cost of treating strokes in the country surpasses US$73 bn per year, the North America acute ischemic stroke diagnosis and treatment market is anticipated to retain its lead through 2020.
 Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1799
 Europe is the second largest market and is mainly fueled by a large population base of geriatrics. Identified as the most rapidly developing regional market for acute ischemic stroke diagnosis and treatment, Asia Pacific is driven by growing awareness among people, increasing number of global companies turning their focus to developing countries in APAC, expanding pool of potential patients, and rising investments in the region.
Some of the leading companies making a significant contribution towards the growth of the global acute ischemic stroke diagnosis and treatment market are Stryker Corporation, Abbott Laboratories, Hitachi, Ltd., Covidien plc, Siemens Healthcare, Penumbra, Inc., GE Healthcare, Philips Healthcare, and Johnson & Johnson.
 Enquiry for discount on this report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1799
 About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
 US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: http://www.transparencymarketresearch.com
0 notes
Text
Acute Ischemic Stroke and Its Market Size, Share, Trends, Growth, Forecast 2021
A stroke is something that happens suddenly and the result may be fatal or it can be cured with medication.  There are different kinds of strokes that may suddenly attack the person, but one of the common strokes is acute ischemic stroke, this comes due to sudden loss of blood circulation to an area of the brain, which results in the loss of neurological function.  This stroke is more common than a hemorrhage.   It is essential to treat this immediately and the patient should have good medical care after the stroke.   One should also be aware of the signs and symptoms before getting the stroke.
The common signs and symptoms for acute ischemic stroke are:
Visual field deficits.
Diplopia.
Dysarthria.
Facial droop.
Ataxia.
Vertigo.
Sudden decrease in level of consciousness
Aphasia.
However, such symptoms can occur alone, but are more likely to come in combination.  The stroke is definitely dangerous as it could prove fatal for some patients and some might get recovered.  Acute ischemic stroke diagnosis and treatment market is very vast, as this is a common occurrence, due to which people around the world are affected and there should be proper diagnosis and treatment for the same.  The diagnosis for this is done with physical examination, blood test, CT scan, magnetic resonance imaging, cerebral angiogram, echocardiogram and carotid ultrasound.  With all the test above one can diagnose and come to the conclusion why the person got the stroke.
Download a free sample report: http://www.marketdataforecast.com/market-reports/global-acute-ischemic-stroke-diagnosis-market-265/request-sample
Acute ischemic stroke diagnosis and treatment market is divided into CT, nuclear imaging, cerebral angiography, MRI and others.  High efficiency and effectiveness of different CT’s have enabled them to dominate the market.  But, the prediction says that it may not do well because the treatment is expensive , diagnosis cost is more and there are technological complexities.   Many people are unable to afford the best treatment because of the cost attached to it.
Customize report: http://www.marketdataforecast.com/market-reports/global-acute-ischemic-stroke-diagnosis-market-265/customize-report
The ischemic stroke market size is definitely big, because the cause for the stroke is common as many suffer from stress, unhealthy lifestyle and other common reasons which disturbs the blood flow to the arteries and the person is affected by the stroke.  In US alone 85% of popular is said to be suffering with acute ischemic stroke.  Asia pacific region has also seen its share in this segment.  The share is increasing also, because in asia pacific countries too people are affected with anxiety, unhealthy lifestyle, stress and many other physical as well as mental reasons due to which such strokes occur in us humans.
Europe is the next market that is expected to emerge as a potential market for acute ischemic stroke diagnosis and treatment market.   Because it is a common  ailment the global market is working towards it to get some better solution and treatment.  This market is definitely huge and one needs to concentrate on the issue to get a better viable solution.   The treatment needs to be reasonable that people can afford and get back to normal life.
The government is working towards making this treatment available by making it available in as many hospitals as possible.  The developing nations should also give importance in getting the cure to their home country that is feasible and which general public can afford.
Buy this report: http://www.marketdataforecast.com/cart/buy-now/global-acute-ischemic-stroke-diagnosis-market-265
Neurovascular products should be promoted in emerging countries as they would help the patients recover from the stroke in a better way.  Proper treatment and medicines are a part of ischemic stroke market size and they should be used appropriately for better results.
Outlook of global acute ischemic stroke market says that it wants to support all the countries who are suffering with this and also wants to render support to emerging markets with proper neurological treatment and devices that would help doctors to diagnose the stroke and give proper treatment.
0 notes
Text
Global Telepresence Robots Market Shares, Strategies, and Forecasts, Worldwide, 2017 to 2023- Acute Market Reports
WinterGreen Research announces that it has published a new study Telepresence Robots: Market Shares, Strategy, and Forecasts, Worldwide, 2017 to 2023.  The 2016 study has 505 pages, 223 tables and figures.  Worldwide Telepresence Robots markets are poised to achieve significant growth.  People like mobility, they like remote communication and telepresence robots add a new dimension to remote communication.
The quality of remote communication is uplifted by the robotic platform approach to connecting people located in different places.  The visualization provided by the telepresence robot is not reproducible by the smartphone and large telepresence systems are not mobile.  So ultimately all people will want access to telepresence robots in order to move around and see for themselves what is going on in another place.
Clearly terrorism is here to stay.  As nationalistic wars decline as a way to settle disputes, terrorism has emerged in spades.  The recent terrorist attacks in Boston, Paris, and Belgium illustrate the risk that civilian populations are exposed to.  Telepresence robots represent the best and perhaps last line of defense against terrorists.  Telepresence robots can go where no man or woman can go, they can go safer, they can go faster, they can provide a presence that might not be achieved in any other way.
There are more civil uses for telepresence robots:  in education, healthcare, business, and manufacturing.  People can drive a telepresence robot around a work environment, around a school, around a hospital to reach people that they night otherwise have a difficult time contacting.
Remote telepresence healthcare diagnosis and treatment market is especially important for the treatment of stroke.  Stroke damage can be mitigated if symptoms are treated within 4 hours of the onset of symptoms, otherwise the stroke damage is likely permanent.  Global telehealth partnerships.  The aim is to integrate diagnostic tools into tele-stroke solutions.
Stroke occurs when a vessel in the brain ruptures or is blocked by a blood clot.  There are two types of strokes: hemorrhagic and ischemic.  An ischemic stroke occurs as a result of an obstruction within a blood vessel supplying blood to the brain, which accounts for 87% of all stroke cases.  A hemorrhagic stroke occurs when a weakened blood vessel ruptures and spills blood into brain tissue.  800,000 people in the U.S. and 15 million people worldwide suffer a stroke each year.
For Full Report Visit@ http://www.acutemarketreports.com/report/telepresence-robots-market
These markets portend to be very large worldwide and represent good uses of telepresence.  The ability of a clinician specialist to diagnose and initiate immediate treatment of a stroke from a gold course or other location is lifesaving.
Manufacturing and engineering telepresence robot uses are expected to proliferate.  Monitoring and telepresence are being combined to achieve remote repairs that provide better customer services at lower cost.  Manufacturing and engineering resources for companies frequently are in different places.  The same is true for IT, the software developer engineers and the software IT users are frequently located in different places.  It is useful to have a mobile device that can be controlled by the engineer to go have a look around when a trouble call comes in from a site.
A remote telepresence device can use monitoring and telepresence to achieve remote repairs.  The ability to integrate the remote physical location with the engineer who knows the system often involves travel, sometimes long arduous travel.  Telepresence and mobile video telecommunications technologies can be very useful in postponing or eliminating the travel.
A mobile, real-time, 3D-hybrid telepresence system permits the user to go and have a look around and talk to different people about the problem without actually being there.  Integration of telepresence images with computer generated virtual environments can be superimposed over the remote real worldview. This integrated system incorporates emerging mobile telecommunications technologies to give rapid and easy access to the real and virtual construction sites from arbitrary locations.  This system allows remote surveillance of the construction site, and integration of real world images of the site with virtual reality representations, derived from planning models, for progress monitoring.
According to Susan Eustis, lead author of the study, “Use of the telepresence robot with the video and microphone capability to achieve remote presence is a vital aspect of personal mobility devices.  Telepresence robots are poised to achieve a vital extension of electronic communication in ways that will become indispensable to everyone soon.”
Telepresence robot device markets at $1.4 billion in 2016 are anticipated to reach $8 billion by 2023 as next generation robotic devices, systems, and instruments are introduced to manage remote presence.  The robotic platform will be extended to include grippers and cameras of all types, sensors and sophisticated navigation software.
For Full Report Visit@ http://www.acutemarketreports.com/report/telepresence-robots-market
The complete report provides a comprehensive analysis including units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players’ success, challenges, and strategies in each segment and sub-segment.  The report covers markets for security, law enforcement, manufacturing, healthcare, education, and business telepresence.
WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software.  The company has 35 distributors worldwide, including Global Information Info Shop, Electronics.ca, Market Research.com, Research and Markets, Report Linker, and Thompson Financial.  It conducts its business with integrity.
WinterGreen Research is positioned to help customers facing challenges that define the modern enterprises. The increasingly global nature of science, technology and engineering is a reflection of the implementation of the globally integrated enterprise.  Customers trust WinterGreen Research to work alongside them to ensure the success of the participation in a particular market segment.
For Same Category Report Visit@ http://www.acutemarketreports.com/category/machines-market
WinterGreen Research supports various market segment programs; provides trusted technical services to the marketing departments.  It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally.  These are all vital market research support solutions requiring trust and integrity.
1. Telepresence Robots Market Description and Market Dynamics 51 1.1 Growing Need For Collaboration Across Distance And Time 51 1.1.1 Globalization Of The Enterprise 52 1.1.2 Globalization Supported By Ubiquitous Communications Networks 54 1.1.3 Elements of a Complete Communications and Collaboration Solution57 1.1.4 US Federal Information Processing Standards 59 1.2 Classic Telepresence Robot 61 1.3 Telepresence Robots 61 1.3.1 Telehealth 63 1.4 RP-VITA Remote Virtual Independent Telemedicine Assistant 65 1.5 Robot as Messenger 65 1.6 Robot as Patient Care Assistant 66 1.7 First Responders 67 1.7.1 First Responder Need for Robots 68 1.8 First Responder Robot Border Patrol 71 1.8.1 Border Patrol and Homeland Security 72
2. Telepresence Robots Market Shares and Market Forecasts 73 2.1 Telepresence Robots Have Broad Market 73 2.1.1 Telepresence Robots Market Driving Forces 76 2.1.2 Remote Telepresence Healthcare Diagnosis and Treatment 81 2.1.3 Manufacturing and Engineering Uses Monitoring and Telepresence to Achieve Remote Repairs 82......
About – Acute Market Reports:
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Name: Chris Paul                                                                    
ACUTE MARKET REPORTS
Designation: Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Website: http://www.acutemarketreports.com
0 notes
niteshagrawals-blog · 6 years
Text
Ischemic Strokes Market Worldwide Key Players Forecasts by Revenue, Growth Rate Till 2023
Market Scenario:
Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. According to the World Health Organization (WHO), stroke accounts for around 17 million deaths annually. As per the Centers for Disease Control and Prevention (CDC), stroke leads to 1 out of every 20 deaths costing around USD 34 billion each year in the U.S. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.
The key strategies adopted by leading industry players incldues new product launches and collaborations. For instance, in April 2016, the novel TransCarotid Artery Revascularization (TCAR) procedure launched by Silk Road Medical, Inc, received FDA approval. This minimally invasive technique is designed to access the common carotid artery. Moreover, in March, 2015, WATCHMAN, a closure device designed to prevent stroke in patients with atrial fibrillation received FDA approval.
Rising cases of ischemia stroke are driving the demand for surgical procedures in stroke treatment. Increasing demand for minimally invasive procedures and advancements in surgical procedures are the key factors boosting the growth of the global ischemic stroke market. High cost of the surgical procedures and excessive usage of medication for the treatment of ischemic stroke are hindering the market growth.
The global market for ischemic stroke is expected to grow at a CAGR of approximately 8.3% during the forecast period 2017-2023.
 Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/5423   Market Segmentation of Ischemic strokes Market: 
The ischemic stroke is segmented on the basis of diagnosis, drug class, surgery and end-users. On the basis of the diagnosis, the market is segmented into Computed Tomography (CT), Magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. On the basis of the drug class, the market is segmented into tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive, and others On the basis of the surgery, the market is segmented into carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy On the basis of the end-user, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.
Avail Premium Discount @ https://www.marketresearchfuture.com/check-discount/5423
Top Players in Ischemic strokes Market:
Abbott Laboratories (U.S.), Medtronic plc (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (U.S.), Koninklijke Philips N.V. (Netherland), GE Healthcare (U.S.), Stryker Corporation (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim (Germany), Sanofi (France), Covidien plc (Ireland), Philips Healthcare (U.S.), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), GE Healthcare (U.S.), Siemens Healthcare (U.S.), Hitachi, Ltd (Japan), Biogen (U.S.), Daiichi Sankyo (U.S.), Pfizer Inc. (U.S.), and others
The emergence of new and cost-effective medication options for the treatment of ischemic stroke could open up new opportunities to the new players in the global ischemic stroke market. Additionally, emerging markets, such as India and China, could also open new opportunities to new players.
Intended Audience
Ischemic     Stroke Drug Suppliers
Ischemic     Stroke Drug Manufacturers
Research     and Development (R&D) Companies
Medical     Research Laboratories
Academic     Medical Institutes and Universities
 Regional Analysis of Ischemic strokes Market: 
The global ischemic stroke market consists of countries namely America, Europe, Asia Pacific, and the Middle East and Africa. The Americas has emerged as the largest market for the global ischemic stroke owing to the favorable government initiatives, technological innovations, and increasing demand for ischemic stroke products. According to the American Heart Association, ischemic stroke is among the top three causes of death in the U.S. and Canada, nearly 795,000 patients suffering from strokes are treated in the 2014.
Europe is the second largest global ischemic stroke market owing to the advancements in the surgical devices technology along with the rising occurrence of acute ischemia stroke cases among the patients. In the European Union, over 31 million people are living with diabetes aged between 20 and 79. This signifies an average diabetes prevalence rate of 8.6% of the adult population. Some other factors driving the market includes the growing percentage of diabetes mellitus population mainly in the developed countries of Europe Asia Pacific is anticipated to unfold as the most promising market for the global ischemic stroke owing to increasing prevalence of stroke cases in this region. China and India are considered as a big market for ischemic stroke within the forecast period. Manufacturers are expanding their operations in Asia Pacific region as these regions hold immense potential for the market growth.
The Middle East region is expected to grow at a faster rate due to the factors such as the extensive development of healthcare infrastructure and growing emphasis on research and development in the healthcare sector.
Major Table of Content for Ischemic strokes Market: 
Chapter 1. Report Prologue
Chapter 2. Market Introduction 2.1 Definition 2.2 Scope of The Study 2.2.1 Research Objective 2.2.2 Assumptions 2.2.3 Limitations   Chapter 3. Research Methodology 3.1 Introduction 3.2 Primary Research 3.3 Secondary Research 3.4 Market Size Estimation   Chapter 4. Market Dynamics 4.1 Drivers 4.2 Restrains 4.3 Opportunities 4.4 Challenges 4.5 Macroeconomic Indicators 4.6 Technology Trends & Assessment 4.5 Macroeconomic Indicators   TOC Continued….! Do You Have Specific Requirement? Ask to Our Experts @ https://www.marketresearchfuture.com/enquiry/5423 
About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India Phone: +1 646 845 9312 Email: [email protected]
0 notes
niteshagrawals-blog · 6 years
Photo
Tumblr media
Ischemic Strokes Market SWOT Analysis, Key Development Areas, Financial Overview and Forecasts Till 2023
Market Research Future published a study report on Global Ischemic strokes Market. This report studies the global market size, industry status and forecast, competition landscape and growth opportunity. Ischemic strokes Market research report categorizes the market by companies, region, type and end-use industry.
Market Scenario:
Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. According to the World Health Organization (WHO), stroke accounts for around 17 million deaths annually. As per the Centers for Disease Control and Prevention (CDC), stroke leads to 1 out of every 20 deaths costing around USD 34 billion each year in the U.S. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.
The key strategies adopted by leading industry players incldues new product launches and collaborations. For instance, in April 2016, the novel TransCarotid Artery Revascularization (TCAR) procedure launched by Silk Road Medical, Inc, received FDA approval. This minimally invasive technique is designed to access the common carotid artery. Moreover, in March, 2015, WATCHMAN, a closure device designed to prevent stroke in patients with atrial fibrillation received FDA approval.
Rising cases of ischemia stroke are driving the demand for surgical procedures in stroke treatment. Increasing demand for minimally invasive procedures and advancements in surgical procedures are the key factors boosting the growth of the global ischemic stroke market. High cost of the surgical procedures and excessive usage of medication for the treatment of ischemic stroke are hindering the market growth.
The global market for ischemic stroke is expected to grow at a CAGR of approximately 8.3% during the forecast period 2017-2023.
Get Exclusive Sample Copy @
https://www.marketresearchfuture.com/sample_request/5423
Market Segmentation of Ischemic strokes Market:
The ischemic stroke is segmented on the basis of diagnosis, drug class, surgery and end-users. On the basis of the diagnosis, the market is segmented into Computed Tomography (CT), Magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. On the basis of the drug class, the market is segmented into tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive, and others On the basis of the surgery, the market is segmented into carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy On the basis of the end-user, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.
Avail Premium Discount @
https://www.marketresearchfuture.com/check-discount/5423
Top Players in Ischemic strokes Market:
Abbott Laboratories (U.S.), Medtronic plc (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (U.S.), Koninklijke Philips N.V. (Netherland), GE Healthcare (U.S.), Stryker Corporation (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim (Germany), Sanofi (France), Covidien plc (Ireland), Philips Healthcare (U.S.), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), GE Healthcare (U.S.), Siemens Healthcare (U.S.), Hitachi, Ltd (Japan), Biogen (U.S.), Daiichi Sankyo (U.S.), Pfizer Inc. (U.S.), and others
The emergence of new and cost-effective medication options for the treatment of ischemic stroke could open up new opportunities to the new players in the global ischemic stroke market. Additionally, emerging markets, such as India and China, could also open new opportunities to new players.
Intended Audience
Ischemic Stroke Drug Suppliers
Ischemic Stroke Drug Manufacturers
Research and Development (R&D) Companies
Medical Research Laboratories
Academic Medical Institutes and Universities
Regional Analysis of Ischemic strokes Market:
The global ischemic stroke market consists of countries namely America, Europe, Asia Pacific, and the Middle East and Africa.
The Americas has emerged as the largest market for the global ischemic stroke owing to the favorable government initiatives, technological innovations, and increasing demand for ischemic stroke products. According to the American Heart Association, ischemic stroke is among the top three causes of death in the U.S. and Canada, nearly 795,000 patients suffering from strokes are treated in the 2014.
Europe is the second largest global ischemic stroke market owing to the advancements in the surgical devices technology along with the rising occurrence of acute ischemia stroke cases among the patients. In the European Union, over 31 million people are living with diabetes aged between 20 and 79. This signifies an average diabetes prevalence rate of 8.6% of the adult population. Some other factors driving the market includes the growing percentage of diabetes mellitus population mainly in the developed countries of Europe
Asia Pacific is anticipated to unfold as the most promising market for the global ischemic stroke owing to increasing prevalence of stroke cases in this region. China and India are considered as a big market for ischemic stroke within the forecast period. Manufacturers are expanding their operations in Asia Pacific region as these regions hold immense potential for the market growth.
The Middle East region is expected to grow at a faster rate due to the factors such as the extensive development of healthcare infrastructure and growing emphasis on research and development in the healthcare sector.
Major Table of Content for Ischemic strokes Market:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
4.5 Macroeconomic Indicators
TOC Continued….!
Do You Have Specific Requirement? Ask to Our Experts @
https://www.marketresearchfuture.com/enquiry/5423
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email:
0 notes
Acute Ischemic Stroke Diagnosis and Treatment Market to Partake Significant Development by 2020
Transparency Market Research announces the release of a new research report titled “Acute Ischemic Stroke Diagnosis and Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”. According to the report, driven by technological advancement, growing prevalence of strokes, and high success rate of treatment surgeries, the global acute ischemic stroke diagnosis and treatment market is likely to expand at a 6.30% CAGR from 2014 to 2020, growing from US$1.2 bn to US$1.9 bn during that time.
Based on type of diagnosis, the acute ischemic stroke diagnosis and treatment market is divided into CT, nuclear imaging, cerebral angiography, MRI, ultrasound, and others. While high efficiency and effectiveness of CTs enabled them to dominate the overall market, this segment is anticipated to witness limited demand by 2020 owing to technological complexities and high cost of diagnosis.
 Request to View Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1799
 On the basis of type of surgery, the acute ischemic stroke diagnosis and treatment market is segmented into carotid endarterectomy, endovascular mechanical thrombectomy, and angioplasty. While carotid endarterectomy dominated the overall market thanks to short treatment duration, high success rate, and easy availability, this segment is anticipated to lose market share over the next five years owing to high risk of side effects.
Geographically, the global acute ischemic stroke diagnosis and treatment market is divided into Asia Pacific, Europe, North America, and Rest of the World. Primarily driven by the rise in acute ischemic stroke surgeries and availability of technologically advanced medical equipment and devices, North America dominates the worldwide acute ischemic stroke diagnosis and treatment market. The American Heart Association states that every year, an estimated 795,000 patients are diagnosed with stroke in the US, a whopping 85.0% of which are identified as acute ischemic stroke. Seeing that the cost of treating strokes in the country surpasses US$73 bn per year, the North America acute ischemic stroke diagnosis and treatment market is anticipated to retain its lead through 2020.
 Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1799
 Europe is the second largest market and is mainly fueled by a large population base of geriatrics. Identified as the most rapidly developing regional market for acute ischemic stroke diagnosis and treatment, Asia Pacific is driven by growing awareness among people, increasing number of global companies turning their focus to developing countries in APAC, expanding pool of potential patients, and rising investments in the region.
Some of the leading companies making a significant contribution towards the growth of the global acute ischemic stroke diagnosis and treatment market are Stryker Corporation, Abbott Laboratories, Hitachi, Ltd., Covidien plc, Siemens Healthcare, Penumbra, Inc., GE Healthcare, Philips Healthcare, and Johnson & Johnson.
 Enquiry for discount on this report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1799
 About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
 US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: http://www.transparencymarketresearch.com
0 notes